IP Library Granted Patent US 7,115,393
Granted Patent B2
US 7,115,393 · App. 10/164,717 · Granted Oct 3, 2006

Melanocortin-1 receptor and methods of use

Assignee: OriGene Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,115,393
App. No.
10/164,717
Granted
Oct 3, 2006
Kind
B2
Abstract

The present invention relates to all facets of novel polynucleotides for melanocortin-1 receptors, the polypeptides they encode, antibodies and specific binding partners thereto, and their applications to research, diagnosis, drug discovery, therapy, clinical medicine, forensic science and medicine, etc. The polynucleotides are useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, determining predisposition to, etc., diseases and conditions especially relating to melanocortin-1, such as melanoma, pigmentation disorders and conditions, inflammation, etc.

Claims (26)

1. An isolated polynucleotide comprising, a polynucleotide sequence coding without interruption for a human MCR-1C (melanocortin receptor 1C), or the complete complement to said polynucleotide sequence,

said MCR-1C having 84% or more amino acid sequence identity along its entire length to the sequence consisting of amino acids 1–316 of SEQ ID NO 2, and 90% or more amino acid sequence identity along its entire length to the sequence consisting of amino acids 317–398 of SEQ ID NO 2, and which has ligand-binding activity, G-protein binding activity, or cAMP production activity, wherein said polynucleotide sequence coding for human MCR-1C hybridizes under high stringency conditions to the complete complement of SEQ ID NO: 1 from nucleotide position 342–1535, and the conditions comprise overnight incubation in 5X SSC, 0.5% SDS, 100 μ/ml denatured salmon sperm DNA and 50% formamide, at 42° C. followed by washing in 0.1% SSC and 0.1% SDS for 30 min at 65° C.

2. An isolated polynucleotide of claim 1 ,

said MCR-1C having 90% or more amino acid sequence identity along its entire length to the sequence consisting of amino acids 1–316 of SEQ ID NO 2, and 95% or more amino acid sequence identity along its entire length to the sequence consisting from amino acids 317–398 of SEQ ID NO 2.

3. An isolated polynucleotide of claim 1 , which codes for the human MCR-1C of SEQ ID NO 2.

4. An isolated polynucleotide of claim 1 , which comprises the polynucleotide sequence set forth in SEQ ID NO 1.

5. An isolated polynucleotide of claim 1 , which codes for the human MCR-1C of SEQ ID NO 3.

6. An isolated polynucleotide comprising a polynucleotide sequence coding for amino acids 367–398 of SEQ ID NO 2.

7. A method of expressing a human MCR-1C polynucleotide in a host cell, comprising

(a) introducing into a host cell the polynucleotide of claim 1 coding for a human MCR-1C polypeptide, wherein said polynucleotide is operably linked to a promoter, and

(b) culturing said host cell under conditions to achieve expression of said polynucleotide and production of said MCR-1C polypeptide.

8. A method of expressing a human MCR-1C polynucleotide in a host cell, comprising

(a) introducing into a host cell the polynucleotide of claim 2 coding for a human MCR-1C polypeptide, wherein said polynucleotide is operably linked to a promoter, and

(b) culturing said host cell under conditions to achieve expression of said polynucleotide and production of said MCR-1C polypeptide.

9. A method of expressing a human MCR-1C polynucleotide in a host cell, comprising

(a) introducing into a host cell the polynucleotide of claim 3 coding for a human MCR-1C polypeptide, wherein said polynucleotide is operably linked to a promoter, and

(b) culturing said host cell under conditions to achieve expression of said polynucleotide and production of said MCR-1C polypeptide.

10. A method of expressing a human MCR-1C polynucleotide in a host cell, comprising

(a) introducing into a host cell the polynucleotide of claim 4 coding for a human MCR-1C polypeptide, wherein said polynucleotide is operably linked to a promoter, and

(b) culturing said host cell under conditions to achieve expression of said polynucleotide and production of said MCR-1C polypeptide.

11. A method of expressing a human MCR-1C polynucleotide in a host cell, comprising

(a) introducing into a host cell the polynucleotide of claim 5 coding for a human MCR-1C polypeptide, wherein said polynucleotide is operably linked to a promoter, and

(b) culturing said host cell under conditions to achieve expression of said polynucleotide and production of said MCR-1C polypeptide.

12. An isolated polynucleotide of claim 1 , which codes for the human MCR-1C of SEQ ID NO:4.

13. An isolated polynucleotide of claim 1 , which codes for the human MCR-1C of SEQ ID NO:5.

14. An isolated polynucleotide of claim 6 , consisting of a polynucleotide sequence coding for amino acid 367–398 of SEQ ID NO:2.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Dec 3, 2018
From: MANUFACTURERS AND TRADERS TRUST COMPANY
To: ORIGENE TECHNOLOGIES, INC.
Reel/Frame 047651/0723 →
SECURITY INTEREST Recorded Nov 17, 2017
From: ORIGENE TECHNOLOGIES, INC.
To: MANUFACTURERS AND TRADERS TRUST COMPANY
Reel/Frame 044159/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2006
From: SHU, YOUMIN; LI, XUAN; YEE, ANTHONY C.; JAY, GILBERT
To: ORIGENE TECHNOLOGIES, INC.
Reel/Frame 017193/0453 →
Continuity (1)
Related Publication 20030228658A1 · Dec 11, 2003